Sagimet Biosciences Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Sagimet Biosciences Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31	2023-12-31
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$56.89M	-$54.45M	-$30.74M
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$51.04M	-$45.57M	-$27.88M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-1.58	$-1.45	$-2.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-1.58	$-1.45	$-2.00

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$35.02M	$75.84M	$75.10M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$116.48M	$160.26M	$96.72M
Everything the company owes — debt, unpaid bills, and other obligations.	–	–	$5.65M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$111.38M	$155.81M	$91.06M

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$45.65M	-$42.44M	-$23.77M